The Experts in Animal Health

print version

Brakke Consulting’s
Animal Health News & Notes for June 13, 2014
Copyright © Brakke Consulting, Inc.
Editor: Lynn Fondon DVM MBA
Brakke Consulting news
Transaction assistance
other news
Giltspur Scientific
Pets At Home
PGG/HSC Feed Company
Zoetis Apoquel
When the Time Is Right

Buying, selling or merging? We can help!

Brakke Consulting assists many clients with mergers, acquisitions and divestitures. Our transaction experts can provide the insight, ability and contacts you need in the animal health, pet, veterinary and specialty chemicals markets. Please contact any of our offices for a confidential consultation.
> Ceva Santé Animale announced a new round of financing. Temasek will invest alongside the management as well as financial investors, such as Euromezzanine and Sagard, historical partners of the group, and CDH Investments. The management retains the position of majority shareholders. (Business Wire)
> Demand for Zoetis’ Apoquel (oclacitinib), used for the treatment of acute and chronic canine pruritus, continues to outpace supply, company representatives say. The company doesn’t anticipate that the drug will be widely available until at least mid-2015. Zoetis has implemented a U.S. allocation protocol for those veterinarians and patients who have begun treatment plans with Apoquel. (DVM360 Magazine)
> Aratana Therapeutics, Inc. announced findings from the company’s ongoing safety and clinical programs at the 2014 American College of Veterinary Internal Medicine (AVCIM) Forum. Safety and efficacy data were highlighted for Aratana’s pet therapeutics programs in pain, cancer immunotherapy, and inappetence. (Wall Street Journal)
> Zoetis Belgium received a positive opinion from European Union’s Committee for Medical Products for Veterinary Use (CVMP) for its Versican Plus Pi vaccine for the treatment of dogs against canine parainfluenza virus and for Versican Plus DHPPi, vaccine to prevent canine distemper virus, canine adenovirus, canine parvovirus and canine parainfluenza virus. (Animal Pharm)
> Birko announced that Beefxide® has been validated in a study conducted by the Center for Meat Safety & Quality in the Department of Animal Sciences at Colorado State University as effective against several strains of pathogenic organisms including E. coli and Salmonella.
Beefxide® is approved by the USDA for application to beef products in the U.S. (company press release) 
> The European Union’s Committee for Medical Products for Veterinary Use (CVMP) approved veterinary vaccine products made by Laboritorios Hipra, Eryseng for the prevention of swine erysipelas in pigs, and Eryseng Parvo against porcine parvovirosis and swine erysipelas in pigs (Animal Pharm).
> Giltspur Scientific announced it has selected AgVet Associates LLC to be its CowSlips representative in the US. Made from highly durable PVC, CowSlips are orthopedic shoes for treating lame cattle. (company press release)
>  PGG/HSC Feed Company has carried out a voluntary recall of its Champion Lamb Texturized B30 product in the northwest states of the US due to health concerns over higher than allowable copper levels. (Animal Pharm)
> Pets at Home pretax profit for the financial year ended March 27 was GBP22.5 million, down on the GBP26.5 million profit reported a year earlier, due to costs associated with its recent IPO. Revenues increased 11% to GBP665.4 million from GBP598.3 million a year earlier. (Alliance News)
>  US – VESICULAR STOMATITIS   There has been an outbreak of vesicular stomatitis virus (VSV) among cattle, goats and horses in Texas, according the World Organisation for Animal Health (OIE). The OIE said 65 animals had been affected so far in Kinney County, in southwestern Texas. Quarantine controls have been implemented without a vaccination strategy. (Animal Pharm)
>  EU – PEDv Live pigs imported from the USA and Canada will henceforth be tested for porcine epidemic diarrhoea virus (PEDv) to prevent the disease being introduced to Europe from North America.  (
>  US – PEDv USDA announced a Federal Order requiring the reporting of new detections of porcine epidemic diarrhea virus (PEDv) and porcine deltacoronavirus (PDCoV) to USDA or State animal health officials. Reporting of swine enteric coronavirus diseases (SECD), which include PEDv and PDCoV, begins immediately effective June 5, 2014. Electronic reporting from the diagnostic laboratories will be fully implemented by June 19, 2014. (Drovers Cattle Network)
>  US – NEW VETERINARY SCHOOL   In August, Arizona’s first veterinary school and the 29th in the country is set to open at Midwestern University. One hundred students will make up the incoming class. (AVMA SmartBrief – Arizona Republic)
>  US – CANCER RESEARCH  Veterinary researchers at Oregon State University have identified a unique group of proteins that indicate the presence of transitional cell carcinoma – the most common cause of bladder cancer – and may lead to a new assay which could better diagnose this disease in both dogs and humans. The group of proteins identified in this research already has a 90% accuracy, and researchers say they hope to improve upon that with continued research. The findings were published recently in the journal Analytical Chemistry. (
>  US – THIRD RABIES CASE IN TEXAS  The Fort Hood Veterinary Center (VETCEN) was notified June 6, that a young fox found on the base tested positive to rabies. After it was humanely euthanized it was submitted to the Texas Department of Health Services for testing. This is the third identified case on Fort Hood since May 12. (KVUE News)
>  US – VETERINARY HOSPITAL EXPANSION  The board of trustees approved the first phase of a $30 million project to expand the Hospital for Companion Animals at Ohio State University.  (The Columbus Dispatch)
>  NORWAY – FARMED FISH The Norwegian Veterinary Institute and the Institute of Marine Research report that wild fish monitoring in 2013 concluded that there are few discoveries of farmed fish causing disease in wild salmonids. (The Fish Site)
In December of 2013 when we were developing our 2014 Animal Health Industry Overview we suggested that at least 5 of the top 15 animal health companies would have ownership changes in 2014. With the announcement of the new round of financing at Ceva completed, we now have four completed and it’s just the end of June. The largest transaction will probably not be technically completed until February of 2015 so we still need one or two more which appears likely in the next 6 months. There are also a number of other transactions in the industry in the works for some medium and smaller companies. The consolidations and new company entries with IPO’s and private funding are keeping the financial firms busy in 2014. These consolidations and ownership changes will impact the industry in a number of ways in the coming years.

Have a great weekend!!

Ron Brakke
Trouble viewing this newsletter?  You can view it online at
This electronic newsletter is the sole property of Brakke
Consulting, Inc.
Any use of the contents herein should be approved by
and appropriately attributed to Brakke Consulting, Inc.
For more information about Brakke Consulting’s services
and syndicated studies, visit our website at
Brakke Consulting, Inc.
12005 Ford Rd., Suite 530
Dallas, TX  75234    USA



en_USEnglish (United States)